نتایج جستجو برای: brca mutation

تعداد نتایج: 292614  

2017
Jihyoun Lee Sungwon Kim Eunyoung Kang Suyeon Park Zisun Kim Min Hyuk Lee

Lack of awareness, the stigma of carrying a genetic mutation, and economic factors are barriers to acceptance of BRCA genetic testing or appropriate risk management. We aimed to investigate the influence of Angelina Jolie's announcement of her medical experience and also health insurance reimbursement for BRCA gene testing on practice patterns for hereditary breast and ovarian cancer (HBOC). A ...

2009
Ingrid Petroni Ewald Patricia Lisboa Izetti Ribeiro Edenir Inêz Palmero Silvia Liliana Cossio Roberto Giugliani Patricia Ashton-Prolla

Women with mutations in the breast cancer genes BRCA1 or BRCA2 have an increased lifetime risk of developing breast, ovarian and other BRCA-associated cancers. However, the number of detected germline mutations in families with hereditary breast and ovarian cancer (HBOC) syndrome is lower than expected based upon genetic linkage data. Undetected deleterious mutations in the BRCA genes in some h...

2016
Zhengqiang Bao Chao Cao Xinwei Geng Baoping Tian Yanping Wu Chao Zhang Zhihua Chen Wen Li Huahao Shen Songmin Ying

Poly (ADP-ribose) polymerase (PARP) inhibitors are a class of small-molecule drugs suppressing PARP enzymes activity, inducing the death of cells deficient in homologous recombination repair (HRR). HRR deficiency is common in tumor cells with BRCA gene mutation. Since their first clinical trial in 2003, PARP inhibitors have shown benefit in the treatment of HRR-deficient tumors. Recently, sever...

Journal: :Molecular cancer therapeutics 2012
Caroline C Clark Jeffrey N Weitzel Timothy R O'Connor

Individuals with an inherited BRCA1 or BRCA2 mutation have an elevated risk of developing breast cancer. The resulting tumors typically lack homologous recombination repair as do a subset of sporadic tumors with acquired BRCA deficiency. Clinical responses to monotherapy with platinum drugs or poly PARP inhibitors (PARPi) have been shown for BRCA-associated cancers. However, there are limited d...

Journal: :American journal of epidemiology 1985
Jessica Dennis Parviz Ghadirian Julian Little Jan Lubinski Jacek Gronwald Charmaine Kim-Sing William Foulkes Pal Moller Henry T Lynch Susan L Neuhausen Susan Domchek Susan Armel Claudine Isaacs Nadine Tung Kevin Sweet Peter Ainsworth Ping Sun Daniel Krewski Steven Narod

Alcohol consumption increases the risk of breast cancer among women in the general population, but its effect on women who carry a BRCA gene mutation is unclear. We conducted a case-control study of 1925 matched pairs of predominantly premenopausal women who carry a BRCA1 or a BRCA2 mutation. Information on current alcohol consumption was obtained from a questionnaire administered during the co...

Journal: :Cancer 2009
Kaylene J Ready Kristen J Vogel Deann P Atchley Kristine R Broglio Kimberly K Solomon Christopher Amos Karen H Lu Gabriel N Hortobagyi Banu Arun

BACKGROUND The likelihood of identifying a BRCA mutation was often calculated using the BRCAPRO model. A previous study suggested that this model may overestimate the chance of detecting a BRCA mutation among women diagnosed with bilateral breast cancer. Studies also suggested that few patients with bilateral breast cancer whose age at first diagnosis is >40 years were mutation carriers. The ob...

2017
Robert T. Neff Leigha Senter Ritu Salani

Ovarian cancer is a heterogeneous disease that encompasses a number of different cellular subtypes, the most common of which is high-grade serous ovarian cancer (HGSOC). Still today, ovarian cancer is primarily treated with chemotherapy and surgery. Recent advances in the hereditary understanding of this disease have shown a significant role for the BRCA gene. While only a minority of patients ...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013
Hetal S Vig Anne Marie McCarthy Kaijun Liao Mirar Bristol Demeter Tracey Fredericks Katrina Armstrong

BACKGROUND Standard BRCA genetic testing criteria include young age of diagnosis, family history, and Jewish ancestry. The purpose of this study was to assess the effect of these criteria on BRCA test utilization in breast cancer patients. METHODS Breast cancer patients aged 18 to 64 years living in Pennsylvania in 2007 completed a survey on family history of breast and ovarian cancer and BRC...

Journal: :Anticancer research 2016
Angiolo Gadducci Maria Elena Guerrieri

Homologous recombination (HR) and base excision repair (BER) are two of the major DNA-repair pathways. The proteins encoded by breast-related cancer antigen (BRCA) and poly(adenosine diphosphate-ribose) polymerases (PARP) are involved in HR and BER, respectively. Tumors with HR deficiency, including those in BRCA mutation carriers, are sensitive to BER blockade via PARP inhibitors. These repres...

2018
Kelsey E. Lewis Karen H. Lu Amber M. Klimczak Samuel C. Mok

Current ovarian cancer screening guidelines in high-risk women vary according to different organizations. Risk reducing surgery remains the gold standard for definitive treatment in BRCA mutation carriers, but research advancements have created more short-term options for patients to consider. The decisions involved in how a woman manages her BRCA mutation status can cause a great deal of stres...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید